Sharon Kochan, Executive VP U.S. Generics at PERRIGO CO (PRGO), sold 2,647 shares at $119.64 ($317K) on 2013-05-14, disclosed to the SEC on 2013-05-16.
Seasonal sale ($317k) by Executive VP U.S. Generics — this insider has traded PRGO in May in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| PRGO | SELL | 2016-03-04 | $373K | — | Filing → |
| PRGO | SELL | 2014-11-12 | $839K | — | Filing → |
| PRGO | SELL | 2013-11-19 | $69K | — | Filing → |